Variations in body mass index of users of depot-medroxyprogesterone acetate as a contraceptive

Contraception
Márcia PantojaArlete Maria dos Santos Fernandes

Abstract

Weight gain is a frequent reason for discontinuing the contraceptive with depot-medroxyprogesterone acetate (DMPA). This 3-year retrospective cohort study assessed body mass index (BMI; kg/m(2)) variations in 379 current or past DMPA users compared to TCu380A intrauterine device (IUD) users matched for age and BMI, categorized into G1 (normal weight), G2 (overweight) or G3 (obese) according to baseline BMI. Variations in weight and BMI were evaluated using analysis of variance. BMI increased progressively in all groups but significantly more in G1 and G2 DMPA users compared to nonusers and according to duration of use. In the G3 subgroup, weight trends were similar in the DMPA and IUD users. Normal and overweight women increased BMI with DMPA use; however, obese women did not increase weight. Weight increase in DMPA users could be associated with metabolic alterations related to duration of use in normal and overweight women and to alterations already present in obese women. Prospective studies are required to determine triggering factors. DMPA use <or=3 years was not associated with weight increase in women with BMI (kg/m(2)) >or=30.

References

Dec 1, 1980·Contraception·K AmatayakulO Thanangkul
Dec 5, 2000·Contraception·E EspeyC Qualls
Jul 6, 2005·International Journal of Obesity : Journal of the International Association for the Study of Obesity·M K ClarkS Nichols
Jun 2, 2006·Obstetrics and Gynecology·UNKNOWN ACOG Committee on Practice Bulletins-Gynecology
Nov 6, 2007·Clinical Obstetrics and Gynecology·Sadia Haider, Philip D Darney
May 13, 2008·Archives of Gynecology and Obstetrics·Sayed BakryFrederick Naftolin
Mar 12, 2009·Thrombosis and Haemostasis·Angeles Blanco-MolinaUNKNOWN RIETE Investigators

❮ Previous
Next ❯

Citations

May 25, 2011·Reviews in Endocrine & Metabolic Disorders·Maria I Rodriguez, Alison B Edelman
Dec 28, 2010·Journal de gynécologie, obstétrique et biologie de la reproduction·V Kerlan
Oct 13, 2011·Journal of Women's Health·Sheila K ModySadia Haider
Aug 26, 2015·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Antonella NapolitanoAngelo Cagnacci
Aug 28, 2014·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Waleska ModestoLuis Bahamondes
Jul 23, 2014·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Priscilla de Nazaré Silva dos SantosArlete Fernandes
Apr 16, 2013·Contraception·Zevidah VickeryJeffrey F Peipert
Nov 28, 2012·Contraception·Christina M NyiratiLynn E T Shaffer
Dec 18, 2010·Diabetes & Metabolism·V Kerlan
Nov 4, 2015·Gynécologie, obstétrique & fertilité·M LobertG Robin
Nov 26, 2015·Obstetrics and Gynecology Clinics of North America·Pamela S Lotke, Bliss Kaneshiro
Apr 24, 2016·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Amanda BlackAnne Marie Whelan
Apr 24, 2016·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Amanda BlackAnne Marie Whelan
Jun 6, 2015·Journal of Pediatric and Adolescent Gynecology·Hannah L H LangeAndrea E Bonny
Oct 30, 2012·American Journal of Obstetrics and Gynecology·Ashley M NaultGina M Secura
May 2, 2014·Contraception·Natália Dal'AvaIlza Monteiro
Oct 11, 2017·Expert Opinion on Drug Safety·Ana Luiza L RochaFernando M Reis
Aug 29, 2016·The Cochrane Database of Systematic Reviews·Laureen M LopezFrans M Helmerhorst
Sep 5, 2018·Journal of Evaluation in Clinical Practice·Raaj Kishore BiswasHafiz T A Khan
Jan 12, 2019·Obstetrics and Gynecology·Shokoufeh DianatChristine Dehlendorf
Feb 6, 2019·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Alessandra Quintino-MoroArlete Fernandes
Jan 14, 2020·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Jaleen SimsJames Shwayder
Sep 14, 2019·Global Health Research and Policy·Gulam Muhammed Al KibriaBrendan Day
Nov 21, 2017·Acta Obstetricia Et Gynecologica Scandinavica·Ingvild Roksvaag, Finn E Skjeldestad
May 11, 2018·European Journal of Preventive Cardiology·Marija GlisicOscar H Franco
Dec 4, 2019·Environmental Toxicology and Pharmacology·Kehinde Samuel OlaniyiLawrence Aderemi Olatunji

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.